Compare ADMA Biologics Inc (ADMA) vs State Street PDR S&P Retail ETF (XRT) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ADMA Biologics Inc vs State Street PDR S&P Retail ETF — how do they compare? ADMA Biologics Inc trades at $9.18 (market cap $2.13B), while State Street PDR S&P Retail ETF trades at $86. The key difference: State Street PDR S&P Retail ETF is trading nearer its 52-week high, ADMA Biologics Inc nearer its low. Which is the better fit depends on your goals.
| ADMA | XRT | |
|---|---|---|
Market Cap | $2.13B | — |
Sector | Health | Broad Market / Factor |
52-Week High | $20.38 | $90.88 |
52-Week Low | $7.60 | $77.28 |
Enterprise Value | $2.20B | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ADMA trades at $9.16, up 2.35% today, with a bullish technical signal from moving averages and oscillators. The company reported strong profitability with a 32.43% net income margin and 43.3% ROE for 2025, though recent EPS results were mixed. Analyst consensus is strongly bullish with an $19.00 price target, but multiple class action lawsuits filed in July 2026 alleging securities fraud create significant near-term uncertainty.
The stock offers substantial upside to analyst targets if legal challenges are resolved favorably, supported by robust fundamentals and projected cash flow growth. Primary risks include the outcome of ongoing litigation and potential reputational damage. Investors should weigh strong financial performance against elevated legal and sentiment risks before establishing a position.
XRT trades at $87.62, down 0.5% on the day, with technical indicators showing a bullish bias from moving averages while oscillators remain neutral. The ETF faces mixed sentiment with recent downgrades citing macroeconomic headwinds despite strong retail sales data. Current price sits near key support at $87 with resistance at $88.
Outlook remains cautious as attractive valuation metrics conflict with consumer sentiment concerns. Investment opportunity exists in retail sector exposure but risks include negative real wage growth and high energy prices pressuring consumer spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About ADMA Biologics Inc
ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.
Read more on ADMA →About State Street PDR S&P Retail ETF
XRT is an equal-weighted ETF that tracks the U.S. retail sector. It provides diversified exposure to apparel, automotive, and online retailers, including well-known names like Amazon, Target, and Costco.
Read more on XRT →
